The global CBCT systems market size was valued at USD 738.7 million in 2021, and is projected to reach USD 1.74 million by 2028, with a CAGR of 7.9% from 2021 – 2028. CBCT plays a vital role in the diagnosis, intervention, and treatment of diseases. Growth of the market is attributed to rising dental disorders and increasing elderly population.
CBCT is a medical imaging technique, where the resultant x-rays are divergent. It enables a thorough analysis of bone structure and tooth orientation, as it provides 3D image of the patient’s anatomy. CBCT plays an important role in diagnosis and offers benefits such as low exposure to radiation, easy operations, fast scan time, cost- effectiveness, and a wide field of applications. Artificial Intelligence (AI) makes CBCT effective than traditional CT scan, which consumes more time. However, in CBCT, work is done by AI precisely within time. Through generated data, physicians do a thorough diagnosis on their patients.
Market Trends, Drivers, Restraints, and Opportunities
- Rapid expansion in health care sector drives the CBCT market.
- Increasing number of global generic population, development in product technology, and rapidly growing medical tourism are expected to fuel the market.
- CBCT investment require around USD 30,000 to upward of USD 70,000.
- New CBCT products are expensive in nature, which is projected to hinder the market growth.
- Development in modern health care products like CBCT is projected to create growth opportunities for the market during the forecast period.
Scope of the Report
The report on the global CBCT system market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes
|
Details
|
|
Report Title
|
Cone Beam Computed Tomography (CBCT) Systems Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
|
|
Base Year
|
2020
|
|
Historic Data
|
2018–2019
|
|
Forecast Period
|
2021–2028
|
|
Segmentation
|
Products (PreXion3D Excelsior CBCT Scanner, Planmeca ProMax 3D Max, Vatech Green CT 2, Dentsply Orthophos SL 3D, and Carestream CS 9300) and End-users (Dental, ENT, Orthopedic Clinics, and Hospitals)
|
|
Regional Scope
|
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
|
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
|
|
Key Players Covered in the Report
|
Carestream Health, Danaher, Planmeca OY, Dentsply Sirona, Vatech Co., Ltd., Cefla s.c., ASAHIROENTGEN IND.CO., LTD., and J. Morita, Curve Beam, and Prexion.
|
Market Segment Insights:
The prexion3D excelsior CBCT scanner segment is expected to hold a major market share during the forecast period
Based on products, the global CBCT system market is segregated as prexion3D excelsior CBCT scanner, planmeca promax 3D max, vatech green CT 2, dentsply orthophos SL 3D, and carestream CS 9300. PreXion3D excelsior CBCT scanner provides a wide field-of-view range (5x5cm to 15x8cm) and a voxel size range of 0.08mm to 0.2mm. The preXion3D excelsior boasts of a competitive technical advantage. These features enable the preXion3D to be used for many types of specialty diagnosis including endodontics, periodontics, implants, orthodontics, and airway analysis.
Planmeca’s proMax 3d max machine offers a wide range of field-of-view settings, ranging from 5×5.5cm to 23x26cm. In addition to the FOV, the promax 3D has a great range in voxel size from 75µm to 600µm. One of the giants in the CBCT market is the Vatech Green CT 2.
The dental segment is expected to hold a major market share during the forecast period
On the basis of end-users, the global CBCT system market is fragmented into ENT, dental, orthopedic clinics, and hospitals. CBCT helps to provide accurate X-ray reports to doctors for a proper diagnosis. The dental segment is projected to expand at a rapid pace, owing to rising dental disorders such as periodontal disorders and tooth loss. Increasing medical tourism, cosmetic dentistry, and introduction of advanced products are expected to drive the segment.
The market in North America is projected to hold a major market share
In terms of regions, the global CBCT market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is estimated to account for the largest share of the global cone beam imaging market, due to growing patient pool suffering from dental disorders, presence of advance healthcare and medical infrastructure, high adoption of advanced technology, and presence of key players in the region.
The market in Asia Pacific is expected to expand at a high CAGR, during the forecast period, due to increasing medical tourism, rising consumer awareness, increasing per-capita income, and improvement in health infrastructure in the region. Modern and updated technology require high costs. Developing and underdeveloped regions find it difficult to manage the costs. However, the World Health Organization (WHO) provides certain equipment, which covers a part of the costs.
Segments
Segments Covered in the Report
The global CBCT systems market is segmented on the basis of
Products
- PreXion3D Excelsior CBCT Scanner
- Planmeca ProMax 3D Max
- Vatech Green CT 2
- Dentsply Orthophos SL 3D
- Carestream CS 9300
End-users
- Dental Clinics
- ENT
- Orthopedic clinics
- Hospitals
Regions
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- Carestream Health
- Danaher
- Dentsply Sirona
- Vatech Co., Ltd.
- Cefla s.c.
- ASAHIROENTGEN IND.CO., LTD.
- J. Morita
- Curve Beam
- Prexion
- Planmeca OY
Competitive Landscape
CBCT market is highly competitive and major market players include Carestream Health, Danaher, Planmeca OY, Dentsply Sirona, Vatech Co., Ltd., Cefla s.c., ASAHIROENTGEN IND.CO., LTD., and J. Morita, Curve Beam, and Prexion.
Demand for CBCT market is increasing due to research & development and advancement of technologies with new products launched by key players. This is estimated to drive the market. Modern technology helps minimize errors as compared to the traditional diagnosis. This is majorly due to advancement in automation as compared to manual diagnosis.
In February 2020, Planmeca, a leading manufacturer in the CBCT systems market, introduced the Planmeca Ultra Low Dose protocol, which is the world’s leading low dose imaging mode that combines high CBCT image quality with low patient doses. Planmeca’s ULD lowered patient dose by 77% without hampering the diagnostic report.
Request For Customization
Enquiry Before Buying
Speak With Analyst
